A novel dimeric dipeptide mimetic of the BDNF selectively activates the MAPK-Erk signaling pathway

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

On the basis of the structure of beta-turn of loop 2 of brain-derived neurotrophic factor (BDNF), its new dimeric dipeptide mimetic bis-(N-hexanoyl-L-seryl-L-lysine) hexamethylenediamide (GTS-201) was created. It activated TrkB and Erk, did not activate Akt, and exhibited neuroprotective activity in vitro at concentrations of 10–5–10–8 M. Unlike the mimetics that activate Erk and Akt, GTS-201 did not exhibit antidepressant properties. For the manifestation of the antidepressant activity of BDNF mimetics, the activation of its both major signaling pathways is required.

作者简介

T. Gudasheva

Zakusov Research Institute of Pharmacology

编辑信件的主要联系方式.
Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

A. Tarasiuk

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

N. Sazonova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

P. Povarnina

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

T. Antipova

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

S. Seredenin

Zakusov Research Institute of Pharmacology

Email: tata-sosnovka@mail.ru
俄罗斯联邦, ul. Baltiiskaya 8, Moscow, 125315

补充文件

附件文件
动作
1. JATS XML

版权所有 © Pleiades Publishing, Ltd., 2017